CRYSTAL BALES: Open Payments
NPI 1417481516 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 43 payments from 13 companies in 2025. Trend: 2023 $491 · 2024 $885 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| Novo Nordisk Inc | 4 | $88 |
| Lilly USA, LLC | 4 | $80 |
| PFIZER INC. | 3 | $67 |
| ABBVIE INC. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| SHIELD THERAPEUTICS INC | 2 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
Products named: OTEZLA, MOUNJARO, Ozempic, JARDIANCE, BREZTRI, NURTEC ODT, ACCRUFER, Veozah.
Industry payments across GA — which companies pay providers there.
